Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-155-6 | CAS number: 17090-93-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
- Report date:
- 2022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 25 June 2018
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- sodium 2-amino-3-carboxypropanoate
- Cas Number:
- 323194-76-9
- Molecular formula:
- C4H7NO4.xNa
- IUPAC Name:
- sodium 2-amino-3-carboxypropanoate
- Test material form:
- solid: particulate/powder
- Details on test material:
- Name: L-aspartic acid, sodium salt monohydrate 1
Batch/Lot number: Z201125/ VG29848563
CAS number: 323194-76-9
Anhydrous substance name: L-aspartic acid, sodium salt, CAS: 17090-93-6
Appearance: Solid, white, crystalline powder
Purity: 98%
Expiry date: 24 November 2022
Storage conditions: Room temperature (15-25 ºC), protected from humidity (tight closed
container)
Constituent 1
- Specific details on test material used for the study:
- Name: L-aspartic acid, sodium salt monohydrate
Lot No.: Z201125 / VG29848563
CAS No.: 323194-76-9
Appearance: white crystalline powder
Manufacturing date: 25 November 2020
Expiry date: 24 November 2022
Storage: At room temperature (15-25°C), protected from humidity
Safety precautions: According to the SDS
Test animals / tissue source
- Species:
- chicken
- Strain:
- other: Strain of chicken: ROSS 308
- Details on test animals or tissues and environmental conditions:
- Source: TARAVIS KFT. 9600 Sárvár, Rábasömjéni utca 129. Hungary
Only the eyes of healthy animals considered suitable for entry into the human food chain were used. Head collection was performed by a slaughter house technician. Heads were removed immediately after sedation of the chickens (sedation was performed by electric current). The heads were transported to Toxi-Coop ZRT. at the earliest convenience for use approximately within 2 hours from collection. The ambient temperature was optimal
(23.7 ºC to 23.9 ºC in first experiment and 19.3 ºC to 20.2 ºC in the additional experiment) during the transport. All eyes used in the assay were from the same groups of eyes collected on one specific day.
After collection, the heads were wrapped with paper moistened with saline, then placed in a plastic box that can be closed (4 5 heads/box).
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- yes, concurrent negative control
- Amount / concentration applied:
- The test item was applied in an amount of 0.03 g by attempting to cover the cornea surface uniformly with the test item, while taking care not to damage or touch the cornea with the application equipment. This procedure was repeated for each test item treated eye.
- Duration of treatment / exposure:
- The time of application was monitored, then after an exposure period of 10 seconds from the end of the application the cornea surface was rinsed thoroughly with 20 mL saline solution at ambient temperature, while taking care not to damage the cornea but attempting to remove all the residual test item if possible. The eye in the holder was then returned to its chamber. The time while the eye was out of the chamber was limited to the minimum.
- Observation period (in vivo):
- na
- Duration of post- treatment incubation (in vitro):
- The control and test eyes were evaluated pre-treatment and at approximately 30, 75, 120, 180 and 240 minutes after the post-treatment rinse. Minor variations within ± 5 minutes were considered acceptable.
- Number of animals or in vitro replicates:
- 3
- Details on study design:
- Treatment
After the zero reference measurements in each experiment, one out of three test item treated eyes was taken out of its chamber and placed on a layer of tissue with the cornea facing upwards. The eye was held in horizontal position over a container to catch waste, while the test item was applied onto the center of the cornea. The test item was applied in an amount of 0.03 g by attempting to cover the cornea surface uniformly with the test item, while taking care not to damage or touch the cornea with the application equipment. This procedure was repeated for each test item treated eye.
The three positive control eyes were treated in a similar way with 0.03 g of Imidazole.
One negative control eye was treated with saline solution. The saline solution was applied in a volume of 30 µL from micropipette, in such a way that the entire surface of the cornea was covered with negative control, taking care not to damage or touch the cornea with the application equipment.
Based on the results of the experiment the test item showed negative outcome (GHS NC), consequently additional experiment was necessary to confirm or discard the negative outcome. All the steps in the additional experiment were the same as in the first experiment.
7.2.2 Test item removal
The time of application was monitored, then after an exposure period of 10 seconds from the end of the application the cornea surface was rinsed thoroughly with 20 mL saline solution at ambient temperature, while taking care not to damage the cornea but attempting to remove all the residual test item if possible. The eye in the holder was then returned to its chamber. The time while the eye was out of the chamber was limited to the minimum.
The minor amount of the test item, which did not prevent the observation process of the corneas, was stuck on the corneas’ surface in all eyes (three eyes) at 30 minutes after the post-treatment rinse in the first experiment. Gentle rinsing with 20 mL saline was performed in all test item treated eyes after the 30, 75, 120 and 180 minutes of observation. The test item treated cornea surfaces were not totally clear at 240 minutes after the post-treatment rinse in the first experiment. This effect was not observed during the additional experiment.
The positive control item Imidazole was stuck on the corneas’ surface in all eyes at 30 minutes after the post-treatment rinse in the first and additional experiments. Gentle rinsing with 20 mL saline was performed in all positive control treated eyes after the 30, 75, 120 and 180 minutes of observation. The positive control treated cornea surfaces were not totally clear at 240 minutes after the post-treatment rinse in the first and additional experiments.
7.2.3 Observation and assessment of corneal effects
The control and test eyes were evaluated pre-treatment and at approximately 30, 75, 120, 180 and 240 minutes after the post-treatment rinse. Minor variations within ± 5 minutes were considered acceptable.
The cornea thickness and cornea opacity were measured at all time points. Fluorescein retention was determined at baseline (t = 0) and 30 minutes after the post-treatment rinse.
7.2.4 Retention of corneas
At the end of the procedures, the corneas were carefully removed from the eyes and placed individually into labeled containers of preservative fluid (4 % formaldehyde) for potential histopathology and stored, protected from light at room temperature.
7.2.5 Histopathology
Histopathology of the corneas was not performed. Corneas are discarded 2 months after the end of the experimental phase.
7.2.6 Demonstration of Proficiency
Prior to routine use of the method Toxi-Coop ZRT. demonstrated the technical proficiency in a separate study (study no.: 392.549.3229) using the ten Proficiency Chemicals according to OECD Test Guideline No. 438.
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- 75 min scoring
- Value:
- >= 2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: ICE class I
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- 240 min scoring
- Value:
- >= 2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: ICE Class I
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- 1
- Value:
- >= 1
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: ICE Class II
- Irritation parameter:
- fluorescein retention score
- Run / experiment:
- 1
- Value:
- >= 0.2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: ICE Class I
- Other effects / acceptance of results:
- other effects: none
Any other information on results incl. tables
The mean values of the treated eyes for maximum corneal thickness change, corneal opacity, fluorescein retention and other observation (morphological effect etc.) are given below. The experimental results are summarized in Tables 1.1-1.6 (Appendix I). The conclusion on eye irritancy was based on the criteria given in OECD guideline on quantitative assessments, shown in Appendices III and IV.
First experiment:
Test Item: L-aspartic acid, sodium salt monohydrate
Observation | Value | ICE Class1 |
Mean maximum corneal swelling at up to 75 min | 2% | I |
Mean maximum corneal swelling at up to 240 min | 2% | I |
Mean maximum corneal opacity | 1.0 | II |
Mean fluorescein retention | 0.2 | I |
Other Observations | None | |
Overall ICE Class1 | 2xI, 1xII |
Positive Control: Imidazole
Observation | Value | ICE Class1 |
Mean maximum corneal swelling at up to 75 min | 32% | IV |
Mean maximum corneal swelling at up to 240 min | 36% | IV |
Mean maximum corneal opacity | 4.0 | IV |
Mean fluorescein retention | 3.0 | IV |
Other Observations | Corneal opacity score 4 was observed in three eyes at 30 minutes after the post-treatment rinse. | |
Overall ICE Class1 | 3xIV |
The positive control Imidazole was classed as corrosive/severely irritating, UN GHS/CLP Classification: Category 1.
1 Details of data interpretation for Isolated Chicken Eye Class are given in Appendices III and IV.
Negative Control: NaCl (9 g/L saline)
Observation | Value | ICE Class1 |
Maximum corneal swelling at up to 75 min | 0% | I |
Maximum corneal swelling at up to 240 min | 0% | I |
Maximum corneal opacity | 0.5 | I |
Fluorescein retention | 0.5 | I |
Other Observations | None | |
Overall ICE Class1 | 3xI |
The negative control NaCl (9g/L saline) had no significant effects on the chicken eye in this experiment.
Additional experiment:
L-aspartic acid, sodium salt monohydrate
Observation | Value | ICE Class1 |
Mean maximum corneal swelling at up to 75 min | 1% | I |
Mean maximum corneal swelling at up to 240 min | 2% | I |
Mean maximum corneal opacity | 0.5 | I |
Mean fluorescein retention | 1.0 | II |
Other Observations | None | |
Overall ICE Class1 | 2xI, 1xII |
Positive Control: Imidazole
Observation | Value | ICE Class1 |
Mean maximum corneal swelling at up to 75 min | 36% | IV |
Mean maximum corneal swelling at up to 240 min | 37% | IV |
Mean maximum corneal opacity | 3.8 | IV |
Mean fluorescein retention | 3.0 | IV |
Other Observations | Corneal opacity score 4 was observed in three eyes at 30 minutes after the post-treatment rinse. | |
Overall ICE Class1 | 3xIV |
The positive control Imidazole was classed as corrosive/severely irritating, UN GHS/CLP Classification: Category 1.
1 Details of data interpretation for Isolated Chicken Eye Class are given in Appendices III and IV.
Negative Control: NaCl (9 g/L saline)
Observation | Value | ICE Class1 |
Maximum corneal swelling at up to 75 min | 2% | I |
Maximum corneal swelling at up to 240 min | 2% | I |
Maximum corneal opacity | 0.0 | I |
Fluorescein retention | 0.0 | I |
Other Observations | None | |
Overall ICE Class1 | 3xI |
The negative control NaCl (9g/L saline) had no significant effects on the chicken eye in this experiment.
Positive and negative control values were within the corresponding historical control data ranges (Appendix II) in the first and the additional experiments.
1 Details of data interpretation for Isolated Chicken Eye Class are given in Appendices III and IV.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this ICET, the overall ICE classes for the test item was 2xI and 1xII in the first and the additional experiments.
According to the guideline OECD 438, L-aspartic acid, sodium salt monohydrate is categorized as “No Category”. - Executive summary:
The purpose of this Isolated Chicken Eye Test (ICET) was to evaluate the potential ocular corrosivity and irritancy of the test item L-aspartic acid, sodium salt monohydrate by its ability to induce toxicity in enucleated chicken eyes. The test compound was applied in a single dose (0.03 g/eye) onto the cornea of isolated chicken eyes in order to potentially classify the test compound as either 1: causing "serious eye damage" (category 1 of the Globally Harmonised System for the Classification and Labelling of Chemicals (GHS/CLP)), or 2: not requiring classification for eye irritation or serious eye damage according to the GHS. Tested corneas were evaluated pre-treatment and at approximately 30, 75, 120, 180, and 240 minutes after the post-treatment rinse. The endpoints evaluated were corneal opacity, swelling, fluorescein retention, and morphological effects. All of the endpoints, with the exception of fluorescein retention (which was determined only at pre-treatment and 30 minutes after test item exposure) were determined at each of the above time points.
Based on the results of the first experiment the test item showed a negative outcome (GHS NC). According to the Study Plan an additional experiment was necessary to confirm or discard the negative outcome.
The positive control Imidazole were grounded before the use in the study. The test item and positive control were applied in an amount of 0.03 g/eye by powdering the entire surface of the cornea attempting to cover the cornea surface uniformly with the test item or positive control, respectively. Three test item treated eyes, three positive control treated eyes and one negative control treated eye (which was treated with 30 µL of NaCl 9g/L saline solution) were used in the first and additional experiments.
After an exposure period of 10 seconds from the end of the application the cornea surface was rinsed thoroughly with ~20 mL saline solution at ambient temperature and this procedure was repeated for each eye.
The minor amount of the test item, which did not prevent the observation process of the corneas, was stuck on the corneas’ surface in all eyes (three eyes) at 30 minutes after the post-treatment rinse in the first experiment. The test item treated cornea surfaces were not totally cleared at 240 minutes after the post-treatment rinse in the first experiment. This effect was not observed during the additional experiment.
Imidazole was stuck on the corneas’ surface in all eyes (three eyes) at 30 minutes after the post-treatment rinse in both cases (first and additional experiments). The Imidazole treated cornea surfaces were not totally cleared at 240 minutes after the post-treatment rinse in the first and the additional experiments.
The overall ICE classes of the test item treated corneas were twice I (based on corneal swelling of 2 % within 240 minutes and based on the fluorescein retention of 0.2) and once II (based on the corneal opacity score of 1.0) in the first experiment and the overall ICE classes of the test item treated corneas were twice I (based on corneal swelling of 2 % within 240 minutes and based on the corneal opacity score of 0.5) and once II (based on the fluorescein retention of 1.0) in the additional experiment.
The positive control Imidazole was classed as corrosive/severely irritating, UN GHS/CLP Classification: Category 1 and the negative control had no significant effects on the chicken eye in in the first and in the additional experiments. So, the positive and negative controls showed the expected results in the first and in the additional experiment. The experiments were considered to be valid.
In this ICET, the overall ICE classes for the test item was 2xI and 1xII in the first and the additional experiments.
According to the guideline OECD 438, L-aspartic acid, sodium salt monohydrate is categorized as “No Category”.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.